Kidney Cancer Therapeutics Market, Global Outlook and Forecast 2022-2028

August 2022 | 64 pages | ID: K9311B5A00BBEN
Market Monitor Global

Abstracts

Kidney cancer is cancer that begins in the kidneys. Your kidneys are two bean-shaped organs, each about the size of your fist. They're located behind your abdominal organs, with one kidney on each side of your spine. In adults, renal cell carcinoma is the most common type of kidney cancer.

This report contains market size and forecasts of Kidney Cancer Therapeutics in Global, including the following market information:

Global Kidney Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Kidney Cancer Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Kidney Cancer Therapeutics include Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer and Exelixis and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Kidney Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Kidney Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Kidney Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Surgery
• Immunotherapy
• Targeted Therapy
• Other

Global Kidney Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Kidney Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Renal Cell Carcinoma
• Renal Pelvis Cancer
• Other

Global Kidney Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Kidney Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Kidney Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Kidney Cancer Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Novartis
• Bristol-Myers Squibb
• Pfizer
• Roche
• Amgen
• Aveo Pharmaceuticals
• Bayer
• Exelixis
• Eisai

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Kidney Cancer Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Kidney Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL KIDNEY CANCER THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Kidney Cancer Therapeutics Market Size: 2021 VS 2028
2.2 Global Kidney Cancer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Kidney Cancer Therapeutics Players in Global Market
3.2 Top Global Kidney Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Kidney Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Kidney Cancer Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Kidney Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Kidney Cancer Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Kidney Cancer Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Kidney Cancer Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Kidney Cancer Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Surgery
  4.1.3 Immunotherapy
  4.1.4 Targeted Therapy
  4.1.5 Other
4.2 By Type - Global Kidney Cancer Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Kidney Cancer Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Kidney Cancer Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Kidney Cancer Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Kidney Cancer Therapeutics Market Size, 2021 & 2028
  5.1.2 Renal Cell Carcinoma
  5.1.3 Renal Pelvis Cancer
  5.1.4 Other
5.2 By Application - Global Kidney Cancer Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Kidney Cancer Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Kidney Cancer Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Kidney Cancer Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Kidney Cancer Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Kidney Cancer Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Kidney Cancer Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Kidney Cancer Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Kidney Cancer Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Kidney Cancer Therapeutics Revenue, 2017-2028
  6.3.2 US Kidney Cancer Therapeutics Market Size, 2017-2028
  6.3.3 Canada Kidney Cancer Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Kidney Cancer Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Kidney Cancer Therapeutics Revenue, 2017-2028
  6.4.2 Germany Kidney Cancer Therapeutics Market Size, 2017-2028
  6.4.3 France Kidney Cancer Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Kidney Cancer Therapeutics Market Size, 2017-2028
  6.4.5 Italy Kidney Cancer Therapeutics Market Size, 2017-2028
  6.4.6 Russia Kidney Cancer Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Kidney Cancer Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Kidney Cancer Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Kidney Cancer Therapeutics Revenue, 2017-2028
  6.5.2 China Kidney Cancer Therapeutics Market Size, 2017-2028
  6.5.3 Japan Kidney Cancer Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Kidney Cancer Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Kidney Cancer Therapeutics Market Size, 2017-2028
  6.5.6 India Kidney Cancer Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Kidney Cancer Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Kidney Cancer Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Kidney Cancer Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Kidney Cancer Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Kidney Cancer Therapeutics Market Size, 2017-2028
  6.7.3 Israel Kidney Cancer Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Kidney Cancer Therapeutics Market Size, 2017-2028
  6.7.5 UAE Kidney Cancer Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Kidney Cancer Therapeutics Major Product Offerings
  7.1.4 Merck Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Kidney Cancer Therapeutics Major Product Offerings
  7.2.4 Novartis Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb Kidney Cancer Therapeutics Major Product Offerings
  7.3.4 Bristol-Myers Squibb Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Kidney Cancer Therapeutics Major Product Offerings
  7.4.4 Pfizer Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Key News
7.5 Roche
  7.5.1 Roche Corporate Summary
  7.5.2 Roche Business Overview
  7.5.3 Roche Kidney Cancer Therapeutics Major Product Offerings
  7.5.4 Roche Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Roche Key News
7.6 Amgen
  7.6.1 Amgen Corporate Summary
  7.6.2 Amgen Business Overview
  7.6.3 Amgen Kidney Cancer Therapeutics Major Product Offerings
  7.6.4 Amgen Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Amgen Key News
7.7 Aveo Pharmaceuticals
  7.7.1 Aveo Pharmaceuticals Corporate Summary
  7.7.2 Aveo Pharmaceuticals Business Overview
  7.7.3 Aveo Pharmaceuticals Kidney Cancer Therapeutics Major Product Offerings
  7.7.4 Aveo Pharmaceuticals Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Aveo Pharmaceuticals Key News
7.8 Bayer
  7.8.1 Bayer Corporate Summary
  7.8.2 Bayer Business Overview
  7.8.3 Bayer Kidney Cancer Therapeutics Major Product Offerings
  7.8.4 Bayer Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Bayer Key News
7.9 Exelixis
  7.9.1 Exelixis Corporate Summary
  7.9.2 Exelixis Business Overview
  7.9.3 Exelixis Kidney Cancer Therapeutics Major Product Offerings
  7.9.4 Exelixis Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Exelixis Key News
7.10 Eisai
  7.10.1 Eisai Corporate Summary
  7.10.2 Eisai Business Overview
  7.10.3 Eisai Kidney Cancer Therapeutics Major Product Offerings
  7.10.4 Eisai Kidney Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Eisai Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Kidney Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Kidney Cancer Therapeutics Market Drivers in Global Market
Table 3. Kidney Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Kidney Cancer Therapeutics in Global Market
Table 5. Top Kidney Cancer Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Kidney Cancer Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Kidney Cancer Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Kidney Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Kidney Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Kidney Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Kidney Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Kidney Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Kidney Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Kidney Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Kidney Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Kidney Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Kidney Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Kidney Cancer Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Kidney Cancer Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Kidney Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Kidney Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Kidney Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Kidney Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Kidney Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Kidney Cancer Therapeutics Product Offerings
Table 32. Merck Kidney Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Kidney Cancer Therapeutics Product Offerings
Table 35. Novartis Kidney Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Kidney Cancer Therapeutics Product Offerings
Table 38. Bristol-Myers Squibb Kidney Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Kidney Cancer Therapeutics Product Offerings
Table 41. Pfizer Kidney Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Kidney Cancer Therapeutics Product Offerings
Table 44. Roche Kidney Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Amgen Corporate Summary
Table 46. Amgen Kidney Cancer Therapeutics Product Offerings
Table 47. Amgen Kidney Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Aveo Pharmaceuticals Corporate Summary
Table 49. Aveo Pharmaceuticals Kidney Cancer Therapeutics Product Offerings
Table 50. Aveo Pharmaceuticals Kidney Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Bayer Corporate Summary
Table 52. Bayer Kidney Cancer Therapeutics Product Offerings
Table 53. Bayer Kidney Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Exelixis Corporate Summary
Table 55. Exelixis Kidney Cancer Therapeutics Product Offerings
Table 56. Exelixis Kidney Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Eisai Corporate Summary
Table 58. Eisai Kidney Cancer Therapeutics Product Offerings
Table 59. Eisai Kidney Cancer Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Kidney Cancer Therapeutics Segment by Type in 2021
Figure 2. Kidney Cancer Therapeutics Segment by Application in 2021
Figure 3. Global Kidney Cancer Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Kidney Cancer Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Kidney Cancer Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Kidney Cancer Therapeutics Revenue in 2021
Figure 8. By Type - Global Kidney Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Kidney Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Kidney Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Kidney Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Kidney Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Kidney Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Kidney Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Kidney Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Kidney Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amgen Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Aveo Pharmaceuticals Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bayer Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Exelixis Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eisai Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)